India's income tax department is conducting searches at Mankind Pharma Ltd's office in New Delhi, a government source told Reuters on Thursday, days after the condom maker's successful public listing on domestic stock exchanges.
BENGALURU, May 11 - India's income tax department is conducting searches at Mankind Pharma Ltd's
office in New Delhi, a government source told Reuters on Thursday, days after the condom maker's successful public listing on domestic stock exchanges.Further details were not immediately available. Mankind Pharma and the IT department did not immediately respond to Reuters' requests for comment.on the Indian stock exchange on Tuesday and surged about 32%, valuing the maker of Manforce condoms at 569.
The stock was last trading down 3.5% at 1,335 rupees on Thursday but was still well above its initial public offering offer price of 1,080 rupees. Mankind Pharma says its Manforce is the top-selling male condom brand in India, where it competes with Reckitt Benckiser Group'sOur Standards:
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
12 of humanity's most important first inventionsThese 12 things are some of the first inventions ever created by mankind.
Read more »
Feds turn antitrust focus to digital pharma adsThe investigation into health data giant IQVIA’s ad tech deal focuses on harm to rivals and increased costs for drugmakers.
Read more »
Pharma CEOs to testify in Senate hearing on insulin pricesThe leaders of major insulin makers and pharmacy benefit managers are set to point to causes of issues on Wednesday in their testimonies during a Senate committee hearing on making the life-saving drug more affordable.
Read more »
Sanders Grills Big Pharma CEOs Over Years of Deadly Price Gouging'We want to know why there are Americans who are dying, or are becoming much sicker than they should, because they can't afford the medicine they need,' said the Vermont Independent.
Read more »
Firm founded by ‘Pharma Bro’ Martin Shkreli files for bankruptcyShkreli even directed Vyera to continue anticompetitive actions while he was serving a prison sentence on securities fraud charges, Vyera said.
Read more »
Pharma CEOs play insulin price blame game during bipartisan Senate grillingCEOs from leading pharmaceutical companies and pharmacy benefit managers spent three hours before a leading Senate committee pointing fingers at one another as the party responsible for high insulin prices.
Read more »